<DOC>
	<DOCNO>NCT02193074</DOCNO>
	<brief_summary>The primary objective study examine clinical efficacy nusinersen ( ISIS 396443 ) administer intrathecally ( IT ) participants infantile-onset SMA . The secondary objective study examine safety tolerability nusinersen administer intrathecally participant infantile-onset SMA .</brief_summary>
	<brief_title>A Study Assess Efficacy Safety Nusinersen ( ISIS 396443 ) Infants With Spinal Muscular Atrophy</brief_title>
	<detailed_description>This study conduct protocol register Ionis Pharmaceuticals , Inc.. In August 2016 , sponsorship trial transfer Biogen .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Muscular Atrophy , Spinal</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<criteria>Key Be bear ( gestational age ) 37 42 week Be medically diagnose spinal muscular atrophy ( SMA ) Have Survival Motor Neuron2 ( SMN2 ) Copy number = 2 Body weight equal great 3rd percentile age use appropriate countryspecific guideline Be able follow study procedure Reside within approximately 9 hour groundtravel distance participate study center , duration study Key Hypoxemia Oxygen ( O2 ) saturation awake less 96 % O2 saturation asleep less 96 % , without ventilation support ) screen evaluation Clinically significant abnormality hematology clinical chemistry parameter Electrocardiogram ( ECG ) , assess Site Investigator , Screening visit would render participant unsuitable participation study Participant 's parent legal guardian willing meet standard care guideline ( include vaccination respiratory syncytial virus prophylaxis available ) , provide nutritional respiratory support throughout study NOTE : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>210 Days</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Spinal Muscular Atrophy</keyword>
	<keyword>SMA</keyword>
	<keyword>SMN</keyword>
	<keyword>SMNRx</keyword>
	<keyword>ISIS-SMNRx</keyword>
	<keyword>ISIS-SMN Rx</keyword>
	<keyword>ISIS 396443</keyword>
	<keyword>IONIS-SMNRx</keyword>
	<keyword>IONIS-SMN Rx</keyword>
	<keyword>Spinraza</keyword>
	<keyword>ENDEAR</keyword>
</DOC>